期刊文献+

三阴性乳腺癌预后的影响因素 被引量:4

Prognostic factors of triple negative breast cancer
下载PDF
导出
摘要 目的探讨三阴性乳腺癌预后的影响因素。方法选取2015年5月至2018年8月江南大学附属医院收治的96例三阴性乳腺癌术后患者作为研究对象。根据体重指数(BMI)将其分为正常或低体重组(n=41)和超重或肥胖组(n=55),正常或低体重组患者的BMI<23 kg/m^(2),超重或肥胖组患者的BMI≥23 kg/m^(2)。比较两组患者的体重指数和临床病理特征与无疾病生存及总体生存的相关性。结果两组患者的BMI值比较,差异有统计学意义(P=0.039)。正常或低体重组和超重或肥胖组5年无疾病生存率分别为80.7%和59.7%(P=0.039),5年总体生存率分别为79.0%和79.7%(P=0.890)。单因素分析结果显示,T分期、N分期、BMI是影响三阴性乳腺癌术后患者无疾病生存的预后因素(P<0.05),T分期、分化程度是影响总体生存的预后因素(P<0.05)。多因素分析结果显示,N分期和BMI是影响患者无疾病生存的独立预后因素(P<0.05),分化程度是影响患者总体生存的独立预后因素(P<0.05)。结论与正常或低体重组三阴性乳腺癌患者相比,超重或肥胖组的患者具有更高的复发转移率,建议三阴性乳腺癌患者控制体重。 Objective To investigate the prognostic factors of triple negative breast cancer.Methods A total of 96 patients with triple negative breast cancer in Affiliated Hospital of Jiangnan University from May 2015 to August 2018 were selected as research objects.They were divided into normal or low weight group(n=41)and overweight or obese group(n=55)according to body mass index(BMI).Patients in the normal or low weight group had a BMI of<23 kg/m^(2),and those in the overweight or obese group had a BMI of≥23 kg/m^(2).The relationship between body mass index and clinicopathological features,disease free survival and overall survival was compared between the two groups.Results There was a significant difference in BMI between the two groups(P<0.05).The 5-year disease free survival were 80.7%and 59.7%for patients with normal or low body weight and overweight or obese,respectively(P=0.039).And the 5-year overall survival were 79.0%and 79.7%for patients normal or low body weight and overweight or obese,respectively(P=0.890).Univariate analysis revealed that T stage,N stage and BMI were the prognostic factors for disease free survival(P<0.05).And T stage and differentiation were the prognostic factors for overall survival(P<0.05).Multivariate analysis demonstrated that N stage and BMI were the independent prognostic factors for disease free survival(P<0.05).And differentiation was the independent prognostic factors for overall survival(P<0.05).Conclusion Triple-negative breast cancer patients with overweight or obese had higher recurrence and metastasis rates compared with counterpart with normal or low body weight.Control weight was recommended for triple-negative breast cancer patients with overweight or obese.
作者 杨开华 YANG Kaihua(Department of Radiotherapy and Oncology,Affiliated Hospital of Jiangnan University,Jiangsu Province,Wuxi214000,China)
出处 《中国当代医药》 CAS 2023年第2期109-113,共5页 China Modern Medicine
关键词 体重指数 三阴性乳腺癌 预后 总体生存 无疾病进展生存 Body mass index Triple negative breast cancer Prognosis Overall survival Disease free survival
  • 相关文献

参考文献5

二级参考文献59

  • 1赵卫红,徐兵河,张频,李青,赵龙妹,孙燕.乳腺癌合并脉管瘤栓的临床病理特点及预后因素分析[J].中华肿瘤杂志,2007,29(2):137-140. 被引量:14
  • 2Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 2006, 295:2492-2502.
  • 3Carlson RW, Moench SJ, Hammond ME, et al. HER2 testing in breast cancer: NCCN Task Force report and recoannendations. J Natl Compr Canc Netw, 2006, 4 Suppl 3 :S1-22.
  • 4Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol, 2007, 8:235-244.
  • 5Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer, 2007, 109:25-32.
  • 6Perez EA, Roche PC, Jenkins RB, et al. HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization. Mayo Clin Proc, 2002, 77:148-154.
  • 7Kandel MJ, Stadler Z, Masciari S, et al. Prevalence of BRCA1 mutations in triple negative breast cancer (BC). Proc Am Soc Clin Oncol, 2006, 24 :abstr 508.
  • 8Herr A, Gluz O, Ting E, et al. Biological characteristics in triple negative high risk breast cancer and their clinical implications. Proc Am Soc Clin Oncol, 2006, 24 : abstr 20032.
  • 9Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol, 2006, 19:264-271.
  • 10Banerjee S, Reis-Fliho JS, Ashley S, et al. Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol, 2006, 57:729-735.

共引文献81

同被引文献41

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部